Zepbound Patients Fear Losing Coverage After CVS Deal for Wegovy
Microdosing weight-loss drugs goes viral, and worries experts
Read at Bloomberg (subscription required)
Blood tests for Wegovy? Diagnostic companies target GLP-1s
Read more at Bloomberg News
Why is Ozempic making me neauseous?
Read at Bloomberg
Ozempic, Wegovy strain state budgets in battle against obesity
Read more at Bloomberg Law
Novo’s Wegovy Approved After Superior Weight-Loss Impact Shown
Novo Nordisk A/S gained U.S. approval for its therapy that helped patients lose about 15% of their body weight on average in trials, an alternative to
